John C.K. Milligan IV - Secretary/CEO subsidiary, Therapeuticsmd, Inc

As of May 12, 2021


John C.K. Milligan IV Net Worth

  • Net worth is estimated to be at least $14.36M
  • Owns at least 5,335,076 units of Therapeuticsmd, Inc stock
  • Sold an estimated value of $2.61M in the last 9 years at Therapeuticsmd, Inc

John C.K. Milligan IV Compensation at Therapeuticsmd, Inc in 2020

  • Earned a $450,000 salary
  • Rewarded $1,479,105 in stock value and options
  • Received a total compensation of $2,275,390

John C.K. Milligan IV Trading

  • Largest purchase of shares was 72,000 units , worth over $198K on October 29, 2019
  • Largest sale of shares was 353,412 units , worth over $2.37M on March 28, 2014
  • In total has made about 17 transactions over 9 years
  • Usually trades in March, August and May, with the busiest year in 2014 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John C.K. Milligan IV Mailing Address

  • Mailing address is 951 Broken Sound Parkway Nw Suite 320 Boca Raton FL 33487 FL

Therapeuticsmd, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert G. Finizio 2020 $600,000 $1,524,751 - $600,000 $21,785 $2,746,536
Robert G. Finizio 2019 $600,000 - $2 $600,000 $22,218 $1,222,220
John C.K. Milligan, IV 2020 $450,000 $1,479,105 - $315,000 $31,285 $2,275,390
John C.K. Milligan, IV 2019 $450,000 - $645,956 $315,000 $29,683 $1,440,639
Edward Borkowski 2020 $430,000 - $3,599,967 $365,500 $81,687 $4,477,154
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm

Therapeuticsmd, Inc Insider Trading

  • The most recent transaction was 29,790 units sold on December 2, 2021 by Michael C Donegan worth over $15.95K
  • In the last 8 years, insiders at Therapeuticsmd, Inc sold an estimated value of $50.32M and bought an estimated value of $4.81M
  • The most active traders are John C.K. Milligan IV, Secretary/CEO subsidiary,  Robert G Finizio, CEO,  and Tommy G Thompson, Director
  • Insider trading is most common in March, with the busiest year in 2018

TherapeuticsMD, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1